Ovarian cancer is the fourth leading cause of cancer deaths in American women. The Yale Early Detection Program for Ovarian Cancer seeks to identify ovarian cancer in its early stages when it is highly curable.
The Gynecologic Oncology Service performs a broad spectrum of services for gynecologic cancer and its complications, including surgery, chemotherapy, radiation therapy, and other procedures.
The Gynecologic Oncology Service offers gynecologic, gastrointestinal, and urologic surgery for previously untreated gynecologic cancers. It also offers surgery for complications and recurrences of gynecologic cancers, as well as for benign gynecological diseases which require difficult surgical procedures.
The Gynecologic Oncology Service offers a full spectrum of chemotherapeutic agents useful in the management of gynecologic cancers. These chemotherapeutic agents may be used both for previously untreated gynecologic malignancies and for the management of recurrent gynecologic malignancies that may have initially failed to respond to chemotherapy or other forms of treatment.
The Gynecologic Oncology Service offers both brachytherapy and external beam radiation therapy for the management of gynecologic cancers including cervical, vaginal and vulvar cancer.
The Gynecologic Oncology Service offers a full-service colposcopy program for the evaluation of patients with abnormal Pap smear or possible recurrences of premalignant or malignant disease in the lower reproductive tract.
All patients treated at the Yale-New Haven Medical Center have slides reviewed at the tumor board. All therapeutic decisions are made by a multidisciplinary panel of experts in the field of gynecologic malignancy diagnosis and management.